Cataract & Refractive

A new bimanual capsulorhexis technique, suing a specially developed instrument allowing a tri-dimensional, sub 1mm capsulorhexis with improved maintenance of the anterior chamber.

In the second of a two-part article Dr David Tanzer says that in today's US Navy the preferred refractive procedure today is wavefront-guided LASIK with a thin flap made with a femtosecond laser.

A new phaco tip (Fine Ozil Tip, MicroSurgical Technology) for use with a proprietary handpiece (Ozil, Alcon Laboratories) improves the safety and efficiency of phacoemulsification using torsional ultrasound with a biaxial microincisional technique. Modification of the phaco parameters improves chopping and segment removal.

Dr Stephen Lane believes that the large variety of available ophthalmic viscosurgical devices now allows the surgeon to tailor the surgery to meet any specific needs a patient may have.

An ophthalmic viscosurgical device is a helpful adjuvant in a multimodal approach for performing cataract surgery in patients with intraoperative floppy iris syndrome, according to three surgeons.

Myopia is a worldwide public health problem and the underlying mechanisms of its development are still unclear. Currently the key challenge is to attract, train and retain young researchers to the field. The European Research Training Network 'MY EUROPIA' adresses these urgent challenges, by innovative and attractive training and networking possibilities and by the establishment of closer private-public partnership links.

Dr David Tanzer explains that in order to achieve the best possible post-operative results with laser vision correction, thorough pre-operative examinations are a must. Patients should be carefully screened, comprehensive clinical work-ups must be carried out and detailed informed consent given. Then, and only then, will surgeons achieve the best results.

This is the first ESCRS congress for 9-month old company, Technolas, which was formed out of a joint venture between Bausch and Lomb's refractive surgery unit and 20/10 Perfect Vision. The new business was founded to innovate in excimer and femtosecond laser technologies, focusing primarily on the correction of presbyopia.

Schwind unveiled its PresbyMAX software module at ESCRS, a presbyopia solution for its AMARIS system. According to Schwind, the software makes it possible, for the first time, to treat emmetropic as well as myopic, hyperopic and astigmatic patients whose accommodative response is limited.

Technique intra-operative findings and postoperative regimen

The Flexivue System, a breakthrough implantable micro-lens treatment for presbyopia from Presbia Coöperatief was unveiled at the show and it is keenly anticipated that it will be in clinical trials in several European countries by the end of the year.

Rayner, the world's first IOL manufacturer, unveiled a dynamic new brand identity at ESCRS and held a seminar today to highlight the success doctors are having with its range of toric IOLs. Headlined A Roadmap to Success the seminar featured presentations from seven European doctors relating their experiences of using Rayner's toric IOLs.

Combind cataract and vitreoretinal surgery

Cataract surgery in patients with pre-existing AMD: Risks and Benefits

New insights into ectopia lentis

Ocular Biometry and Straylight

New at congress, Zeiss Toric Solution is a combination of tools to allow physicians to implant and align toric lenses faster and easier.

Anterior chamber lenses in the management of subluxated lenses

PRK and LASEK in children

IOLs anatomical prerequisites for accommodation?

Patients share their postoperative experiences and the dramatic changes in their lives bought about by undergoing refractive lens surgery. Patients had either high myopia, hyperopia and/or severe astigmatism and each received the AT.LISA 366D, a one-piece, 4 haptic multifocal IOL and each has found a new lease of life.

Before and after cataract surgery

Are the years of research and advocacy at last reaping rewards?

An interview with Dr Mark Tomalla about his experience with the Crystalens HD IOL.

Professor Auffarth of Heidelberg University Eye Clinic reports on the results of his implantation of the LENTIS Mplus and explains how the lens works using a new unique optical principle.

Allergan Inc. expects its ketorolac tromethamine ophthalmic solution 0.45% (Acuvail) to be available in the United States in September. The preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the treatment of pain and inflammation after cataract surgery and received FDA approval at the end of July, the company announced.

Results from the Omeros Corporation for the Phase I/Phase II clinical trial of OMS302, a proprietary combination of an anti-inflammatory agent and an agent that causes pupil dilation (mydriasis) are said to be promising.

Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. EphA2 encodes an enzyme that plays a role in the repair of proteins in the lens of the eye after they become damaged and clump together, according to the investigators.

ACUVAIL (Allergan), the ketorolac tromethamine ophthalmic solution, which acts as a treatment for inflammation and pain after cataract surgery has been approved by the FDA.

The use of implantable collamer lenses (ICLs) to correct moderate to high myopia can offer predictable and stable results over a long period of time, according to a report published in the July issue of Archives of Ophthalmology.